Pion

Pion is a long-established, privately-held provider of specialized instrumentation and analytical services for the pharmaceutical and food industries. Its core technology platform centers on real-time, in-situ monitoring systems for dissolution, permeability, and physicochemical characterization, which are critical for formulation development of both oral and injectable drugs. The company operates a business-to-business (B2B) model, selling instruments and offering contract services, positioning it as a key enabler for drug developers seeking to streamline R&D and reduce reliance on animal models. With a focus on tools that predict in vivo performance, Pion addresses a persistent bottleneck in bringing new therapies to market.

Suite of analytical instruments for real-time, in-situ monitoring of dissolution, permeation, solubility, and physicochemical properties of drug compounds and formulations. Key platforms include Rainbow R6 (dissolution/permeation), SCISSOR N3 (injection site simulation), and SiriusT3 (compound screening).

Pion competes in the niche of specialized formulation development tools against segments of larger life science tool companies (e.g., Agilent, Waters, Spectris) and other specialized vendors. Its differentiation is based on integrated, real-time in-situ measurement capabilities for specific formulation challenges, particularly in dissolution-permeation and injectable simulation.